Dr. Wang Discussed CLARITY Clinical Trial Enrollment at Presentation in Miami
Robert Wang, MD, Texas Retina’s Director of Clinical Research for Plano, recently spoke about the CLARITY clinical trial at a meeting of retina specialists held in Miami, Florida. A global, multi-center Phase
read more
Dr. Abbey Presented First-Year Results of DAVIO 2 Clinical Trial at Hawaiian Eye and Retina 2025
Texas Retina’s Ashkan M. Abbey, MD, presented “DAVIO 2: Year 1 Results from a Phase 2, Multicenter, Non-Inferiority Trial of EYP-1901 (Vorolanib Intravitreal Insert) versus Aflibercept for Previously-Treated Wet Age-Related Macular Degeneration”
read more
Understanding Your Insurance Coverage in the New Year: How Prior Authorizations Can Impact Retina Care
Health insurance policies and coverage vary greatly. As we start a new year, it is important to understand how your specific plan works and how that can affect your retina care. Referrals
read more
Which Vitamins Help Your Eyes?
You know that eating a diet low in fat and rich in fruits, vegetables and whole grains is important for your overall health. Did you know that the same healthy diet is
read more
Dr. Abbey Discusses Latest Dry AMD Treatment Research on New Podcast Episode
While anti-VEGF injections are widely used to treat patients with wet age-related macular degeneration (AMD), there have been limited treatment options available for dry AMD other than AREDS vitamin formulations and lifestyle
read more
Office Closures for 1/10/2025
Due to the winter weather, the following Texas Retina offices are CLOSED today, January 10, 2025: Dallas North Athens Denton Grapevine Mansfield Sherman Wichita Falls If you have an appointment scheduled that
read more
Winter Weather Closures
Due to the winter weather, the following Texas Retina offices are CLOSED today, January 9, 2025: Dallas North Arlington Athens Frisco Denton Fort Worth Grapevine Plano Sherman Wichita Falls If you have
read more
Dr. Anand Participated in Research on New Gene Therapy Drug for X-linked Retinitis Pigmentosa Published in American Journal of Ophthalmology
The two-year results of the Phase I/II, multi-center HORIZON clinical trial of the new subretinal gene therapy drug AGTC-501 for X-linked retinitis pigmentosa were recently published in the American Journal of Ophthalmology.
read more
2025 New Year’s Resolutions for Your Eyes
As 2025 begins, it is the perfect time to commit to living a healthy lifestyle. Here are eight New Year’s resolutions to improve your eye health and protect your vision: 1. Schedule
read more